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Background: Previous studies have demonstrated that pre-pubertal aryl hydrocarbon receptor knockout (AHRKO)
mice have slow antral follicle growth and reduced capacity to produce estradiol compared to wild-type (WT) mice.
Although previous studies have suggested that this is likely due to a reduced ability of the AHRKO follicles to
respond to follicle-stimulating hormone (FSH), this possibility was not directly tested. Thus, the goal of these studies
was to test the hypothesis that low FSH responsiveness is responsible for the slow growth and reduced estradiol
production observed in pre-pubertal AHRKO versus WT antral follicles.
Methods: Antral follicles from WT and AHRKO mice were cultured with varying amounts of FSH (0–15 IU/mL) for
up to 7 days, and subjected to measurements of growth, FSH receptor and steroidogenic regulator expression,
sex steroid hormone levels, and inhibin beta-A expression. General linear models (GLM) for repeated measures were
used to compare follicle diameters over time among treatments. If the global tests from GLM were significant,
Tukey’s tests were used for pairwise comparisons. Remaining comparisons among groups were performed using
one-way analysis of variance followed by Tukey’s post hoc test.
Results: The results indicate that FSH stimulated growth in both WT and AHRKO follicles, but that high levels of FSH
(10–15 IU/mL) were required for AHRKO follicles to reach maximal growth, whereas lower levels of FSH (5 IU/mL)
were required for WT follicles to reach maximal growth. Further, FSH stimulated expression of FSH receptor,
steroidogenic factors, and inhibin beta-A as well as production of steroid hormones in both WT and AHRKO follicles,
but the degree of stimulation differed betw een WT and AHRKO follicles. Interestingly, FSH treatment increased
expression of FSH receptor, some steroidogenic regulators, inhibin beta-A, and steroid hormone production more in
AHRKO follicles compared to WT follicles.
Conclusions: Collectively, these data suggest that the slow growth, but not reduced steroidogenesis in AHRKO
follicles, is due to their reduced ability to respond to FSH compared to WT follicles. These data also suggest that the
AHR may contribute to the ability of FSH to stimulate proper follicle growth, but it may not contribute to FSH-induced
steroidogenesis.
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The aryl hydrocarbon receptor (AHR) is a ligand-
activated transcription factor [1] that has been shown to
have important biological roles in ovarian function [2-8].
Specifically, previous studies indicate that pre-pubertal
aryl hydrocarbon receptor knockout (AHRKO) mice
have slower antral follicle growth and a reduced ca-
pacity to produce estradiol compared to wild-type (WT)
mice [2-8]. Further, the slow growth and reduced es-
tradiol production is only observed in pre-pubertal
AHRKO mice, but not in sexually mature AHRKO
mice [8].
One possible explanation for the slow follicle growth
and reduced production of estradiol in pre-pubertal
AHRKO mice compared to pre-pubertal WT mice may
be that pre-pubertal AHRKO mice have a reduced ca-
pacity to respond to follicle-stimulating hormone (FSH)
compared to pre-pubertal WT mice. FSH is critically im-
portant for promoting estradiol production in granulosa
cells, and estradiol is the hormone that directly stimu-
lates growth in antral follicles [9,10]. Given that the
levels of FSH are generally low prior to puberty and dra-
matically rise after puberty, it is possible that AHRKO
mice are able to overcome their potentially low ability to
respond to FSH prior to puberty by the presence of
higher FSH levels after they become sexually mature.
These possibilities are supported by previous studies
that show that AHRKO follicles have reduced mRNA
expression of FSH receptors (Fshr) as well as a reduced
number of FSH binding sites compared to WT follicles
[5,8]. Further, they are supported by studies indicating
that the AHR and FSH pathways may interact to regu-
late transcription of the Fshr because the AHR binds
to aryl hydrocarbon response elements in the pro-
moter regions of the Fshr and an E-box binding site in
the mouse ovary [5,11].
If pre-pubertal AHRKO follicles are less responsive
than pre-pubertal WT follicles to FSH, this may lead to
reduced estradiol biosynthesis and slow follicle growth.
This is because binding of FSH to FSHR promotes cyto-
chrome P450, family 19, subfamily A, polypeptide 1
(CYP19A1) expression [12], the enzyme that converts
theca cell-produced androgens (i.e., dehydroepiandros-
terone and androstenedione) into estrogens (i.e., estra-
diol and estrone) [9,10,13], and the estrogens then
stimulate proliferation of granulosa cells to promote fol-
licle growth [9,14]. Thus, the current study was designed
to test the hypothesis that low FSH responsiveness is
responsible for the slow growth and reduced estradiol
production observed in pre-pubertal AHRKO versus
pre-pubertal WT antral follicles.
To test this hypothesis, antral follicle growth was com-
pared in follicles from pre-pubertal WT and AHRKO
mice in response to varying concentrations of FSH. Asbalanced steroid hormone synthesis is crucial for antral
follicle growth [9], the levels of steroid hormones and
the expression of factors that regulate steroidogenesis
were also compared in WT and AHRKO follicles cultured
with FSH. Further, studies also show that FSH regulates
the levels of inhibin beta-A (INHBA) in antral follicles
during granulosa cell differentiation [15-17]; and that re-
duced levels of Ahr mRNA are related to high levels of
Inhba mRNA in antral follicles [18]. Thus, the levels of
Inhba mRNA were compared in WTand AHRKO follicles
cultured with varying concentrations of FSH.
Methods
Chemicals
Fetal bovine serum (FBS) was obtained from Atlanta Bio-
logicals (Lawrenceville, GA). Human recombinant FSH
was obtained from Dr. A.F. Parlow from the National
Hormone and Peptide Program (Harbor-UCLA Medical
Center, Torrance, CA). Penicillin, streptomycin, ITS (insu-
lin, transferrin, selenium), antibiotic antimycotic solution,
and ampicillin were obtained from Sigma-Aldrich
(St. Louis, MO). Alpha-minimal essential medium
(α-MEM) was obtained from Invitrogen (Carlsbad, CA).
Animals
The AHRKO mice were generated by Schmidt et al. [19]
and are in C57BL/6J background, along with their WT
littermates. Only homozygous mice (WT and AHRKO)
were used from breeding colonies maintained by our labora-
tory at the University of Illinois at Urbana-Champaign, Vet-
erinary Medicine Animal Facility. Mice were provided with
food and water for ad libitum consumption, and maintained
in a temperature and light controlled room (24 ± 1°C, 12 h
daylight/12 h dark cycle) with 35 ± 4% relative humidity.
Genetic screening was performed using ear tissue punches
as previously described [5,6]. Female WTand AHRKO mice
were euthanized by carbon dioxide inhalation. The ovaries
were removed and early antral follicles were isolated as de-
scribed below. All animal care, euthanasia, and tissue collec-
tion were approved by the Institutional Animal Use and
Care Committee at the University of Illinois.
Antral follicle isolation
Ovaries were removed from pre-pubertal WTand AHRKO
mice on post-natal day (PD) 30–32 (3–6 mice per genotype
per experiment), placed in α-MEM, and cleaned of both
interstitial tissue and small follicles using fine watch maker
forceps under a dissecting microscope. WT and AHRKO
mice on PDs 30–32 were considered to be of a pre-
pubertal age because of their lack of a vaginal opening and
lack of regular estrous cyclicity. Approximately 20–30 early
antral follicles (260–400 μm) were mechanically isolated
per ovary, pooled, and randomly assigned by genotype
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as described below.
Measurement of follicle growth
Follicle growth was evaluated in cultured antral follicles as
previously described [6,20]. Briefly, early antral follicles
from WT and AHRKO mice on PDs 30–32 (3–6 mice per
genotype per experiment) were placed individually in
96-well culture plates with 150 μL α-MEM, which was
immediately replaced with 150 μL of supplemented
α-MEM containing 5% FBS, 1% ITS (10 ng/mL insu-
lin, 5.5 ng/mL transferrin, and 5.5 ng/mL selenium),
100 U/mL penicillin, 100 mg/mL streptomycin, and 0,
5, 10 or 15 IU/mL FSH. Follicles were then incubated
for 7 days at 37°C in 95% air, 5% carbon dioxide, and
humidity saturated. Follicle growth patterns were exa-
mined by measuring follicle diameters in perpendicular
axes every 24 h using an inverted microscope equipped
with a calibrator ocular micrometer as described by Miller
et al. [20]. Culture media were collected on days 3 and 7
and subjected to measurements of steroid hormone levels
as described below. Follicles were discarded from cultures
if they were dark in appearance or if they could not retain
their oocyte enclosed within the granulosa cell mass. At
least three separate cultures per FSH treatment group in
WT and AHRKO mice were performed. Each experiment
contained 10–16 follicles per treatment. The sizes of follicles
per treatment were averaged in each experiment and then
data across separate cultures were averaged. At the end of
culture, follicles were snap-frozen and stored at −80°C until
quantitative PCR (qPCR) analyses as described below.
Measurement of steroid hormone levels
Culture media samples were subjected to enzyme linked
immunoassays (ELISA) using kits for measurement of
progesterone and androstenedione (DRG International
Inc., Mountainside, NJ), dehydroepiandrosterone (DHEA;
Alpco Diagnostics, Salem, NH), and estradiol (Calbiotech,
Spring Valley, CA). All samples from 5–15 IU/mL FSH
treatments were diluted 1:2 (v/v) for androstenedione and
1:5 (v/v) for progesterone assays. Samples collected on
days 3 and 7 were diluted 1:10 (v/v) and 1:100 (v/v), re-
spectively, for estradiol assays. Hormone levels were mea-
sured on day 3 because this is a time at which media need
to be changed in the culture system to maximize follicle
growth. Hormone levels were measured on day 7 because
this was the last day of culture. Then, a sum of day 3 and
day 7 hormone levels was made to represent total hor-
mone production by follicles as they grew in culture. All
ELISA procedures were performed according to the
manufacturer’s protocol. α-MEM medium was used as
background control. Lyphochek Immunoassay Plus con-
trols (Bio-Rad laboratories, Inc.) containing known
amounts of specific hormones were included as positivecontrols in every assay. All samples were run in duplicate,
and values were calculated by multiplying by the corre-
sponding dilution factor. The analytical sensitivities, as deter-
mined by the ELISA kit manufacturers, were 0.045 ng/mL
for progesterone, 0.005 ng/mL for DHEA, 0.019 ng/mL for
androstenedione, and 10 pg/mL for estradiol. No samples
were below the limit of detection. Intra-assay and inter-
assay coefficients of variation for all assays were <10%.Quantitative real-time polymerase chain reaction (qPCR)
Total RNA (1–2 μg) from pooled antral follicles was
extracted using the RNeasy Mini Kit (Qiagen, Inc., Valencia,
CA) and then converted to cDNA using iScript cDNA
synthesis kit (Bio-Rad Laboratories Inc., Hercules, CA)
according to the manufacturers’ protocols. The cDNA
was amplified by qPCR as previously described [21]
using a CFX96 Real-time System C1000 Thermal Cycler
(Bio-Rad Laboratories Inc., Hercules, CA) and accom-
panying software according to the manufacturer’s instruc-
tions. To allow analysis of the amount of cDNA in the
exponential phase, a standard curve from five serial dilu-
tions was generated using cDNA from a pool of WT and
AHRKO antral follicles. Specific qPCR primers (Integrated
DNA Technologies, Inc, Coralville, IA) for the genes of
interest and annealing temperatures are listed in Table 1.
SsoFast EvaGreen Supermix (Bio-Rad Laboratories Inc.,
Hercules, CA) was used as dye for all qPCR analyses. A
melting curve was generated at 55–90°C to confirm the
generation of a single product, and PCR products were
loaded in 3% agarose gel to confirm the product size
according to Table 1. Beta actin (Actb) was used for each
sample as an internal control. Relative transcript amount
was calculated by a mathematical model developed by
Pfaffl [22]. Briefly, the method calculates the relative
expression ratio of the target gene based on the amp-
lification efficiency of each amplicon and the ΔCt of the
treated samples versus the vehicle control. These ratios
were then compared to the expression of the reference
gene Actb.Statistical analysis
The data were analyzed using SAS 9.2 (Statistical Analysis
System Institute, Inc.). General linear models (GLM) for
repeated measures were used for comparisons over time
in follicle cultures. If the global tests from GLM were sig-
nificant, Tukey’s tests were used for pairwise comparisons.
Multiple comparisons between experimental groups were
conducted on data obtained from at least three independ-
ent experiments using one-way analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Data were
expressed as means ± SEM. Statistical significance was
assigned at p ≤ 0.05.
Table 1 Primers used in real-time qPCR analysis




Beta actin Actb F: ctggcaccacaccttctac 55.0 238 NM_007393
R: gggcacagtgtgggtgac
Cytochrome P450, family 11,
subfamily A, polypeptide 1
Cyp11a1 F: agatcccttcccctggcgacaatg 60.0 192 NM_019779
R: cgcatgagaagagtatcgacgcatc
Cytochrome P450, family 17,
subfamily A, polypeptide 1
Cyp17a1 F: ccaggacccaagtgtgttct 56.0 250 NM_007809
R: cctgatacgaagcacttctcg
Cytochrome P450, family 19,
subfamily A, polypeptide 1




Fshr F: gcagatgtgttctccaacctacc 61.0 172 NM_013523
R: ggagagactggatcttgtgaaagg
Hydroxy-delta-5-steroid dehydrogenase,
3 beta- and steroid delta-isomerase 1
Hsd3b1 F: caggagaaagaactgcaggaggtc 59.5 280 NM_008293
R: gcacacttgcttgaacacaggc
Steroidogenic acute regulatory protein Star F: cagggagaggtggctatgca 57.0 262 NM_011485
R: ccgtgtcttttccaatcctctg
Inhibin, beta-a Inhba F: tcacctttgccgagtcaggc 59.0 97 NM_008380
R: ccacacttctgcacgctcca
F, forward; R, reverse.
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Effects of FSH on in vitro antral follicle growth
To evaluate whether WT and AHRKO follicles respond
similarly to FSH in terms of follicle growth, early antral
follicles from WT and AHRKO mice were cultured with
vehicle (supplemented α-MEM; 0 IU/mL FSH) or in-
creasing concentrations of FSH (5–15 IU/mL; Figure 1)
and their diameter measured every 24 h for a total cul-
ture time of 7 days. Wild-type antral follicles treated
with 0, 5, 10 or 15 IU/mL FSH were able to grow to a
similar degree over the 7-day culture period (Figure 1A).
AHRKO antral follicles significantly grew starting at day
5 in the presence of 10 or 15 IU/mL FSH or they grew
starting at day 6 in the presence of 5–15 IU/mL FSH, as
compared to AHRKO follicles with no FSH treatment
(Figure 1B). When change in follicle diameter from day
0 to day 7 of culture was compared in WT and AHRKO
follicles (Figure 1C), WT follicles with no FSH treatment
grew more than AHRKO follicles with no FSH treat-
ment and WT follicles treated with 5 IU/mL FSH grew
more than AHRKO follicles treated with 5 IU/mL FSH
treatment. However, WT and AHRKO follicles grew to a
similar degree in response to higher concentrations of FSH
(10 and 15 IU/mL).
Effects of FSH on theca cell derived steroidogenic factors
and steroid hormones
To evaluate whether WT and AHRKO follicles respond
similarly to FSH in terms of estradiol production, levels
of steroidogenic enzymes and sex steroid hormones werecompared in WT and AHRKO follicles in response to
FSH. Normal estradiol production requires expression of
steroidogenic factors and production of sex steroid hor-
mones in both the thecal cells and granulosa cells of antral
follicles [23-25]. Thus, we first compared thecal cell-
derived expression of steroidogenic factors and sex steroid
hormone levels in WT and AHRKO follicles in response
to FSH. Specifically, we examined mRNA levels of ste-
roidogenic acute regulatory protein (Star), cytochrome
P450, family 11, subfamily A, polypeptide 1 (Cyp11a1),
cytochrome P450, family 17, subfamily a, polypeptide 1
(Cyp17a1) and hydroxy-delta-5-steroid dehydrogenase, 3
beta- and steroid delta-isomerase 1 (Hsd3b1) because
these factors are in thecal cells and they are transcriptio-
nally regulated [23,24].
In both WT and AHRKO follicles, mRNA levels for
theca-cell derived factors increased with either low or
high concentrations of FSH (Figures 2A-2D). Further,
both WT and AHRKO follicles had similar levels of Star
(Figure 2A), Cyp11a1 (Figure 2B), Cyp17a1 (Figure 2C),
and Hsd3b1 mRNA regardless of the FSH concentration
(Figure 2D).
Normal estradiol production also requires the produc-
tion of progesterone, DHEA and androstendione by thecal
cells in the follicle. Thus, we evaluated whether WT and
AHRKO follicles respond similarly to FSH in terms of
production of progesterone, DHEA, and androstendione.
Theca cell-derived progesterone (Figure 2E) and DHEA
(Figure 2F) significantly increased in media samples from
WT and AHRKO follicles treated with each concentration
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Figure 1 Comparison of follicle growth in response to FSH
treatment in WT and AHRKO follicles. Early antral follicles from
pre-pubertal WT (A) and AHRKO (B) ovaries were cultured in
supplemented media in the presence of 0–15 IU/mL FSH for 7 days.
Growth of follicles was monitored every 24 h by measuring follicle
diameter in perpendicular axes and plotted as follicle diameters.
(C) Total percent change in WT and AHRKO follicle diameters from
day 0 to day 7 of culture. Graphs represent the mean ± SEM from
three separate cultures, each with 10–16 follicles per genotype.
The asterisk (*) above the dotted line indicates significant differences
(p ≤ 0.05) from 0 IU/mL FSH at the same day of follicle growth,
using a GLM followed by Tukey’s test. The letter “a” above the bars
indicates significant difference (p ≤ 0.05) from WT follicles within the
same FSH treatment group and the letter “b” above the bar
indicates significant difference (p ≤ 0.05) from 0 IU/mL FSH in the
same genotype, using one-way ANOVA followed by Tukey’s test as a
post hoc test.
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follicles of the same genotype with no FSH treatment.
Theca cell-derived androstenedione (Figure 2G) signifi-
cantly increased only in media samples from AHRKO fol-
licles treated with 5 IU/mL FSH compared to media
samples from AHRKO follicles with no FSH treatment.
Effects of FSH on steroidogenic factors and steroid
hormones in granulosa cells
Normal estradiol production requires granulosa cell ex-
pression of Fshr and conversion of thecal-derived andro-
gens to estradiol in the granulosa cells. Further, FSH
may regulate the expression of its own receptor (Fshr) in
granulosa cells [9,26-29] and binding of FSH to FSHR
leads to increased transcription of Cyp19a1 in granulosa
cells [12], the enzyme that converts theca cell-derived
androgens into estradiol. Thus, we evaluated whether
FSH responsiveness is reduced in AHRKO versus WT
follicles by altering granulosa cell-derived factors. Speci-
fically, at the end of the 7-day culture period with in-
creasing concentrations of FSH, follicles were processed
for analysis of gene expression of Fshr and Cyp19a1 by
qPCR. Treatment with FSH increased expression of Fshr in
both WT and AHRKO follicles, but FSH (10 and 15 IU/mL)
significantly increased expression of the Fshr to a greater
degree in AHRKO follicles compared to WT follicles
(Figure 3A). Further, down-regulation of Fshr expression
occurred in WT, but not AHRKO follicles (Figure 3A).
Levels of Cyp19a1 mRNA were similar in WT and AHRKO
follicles treated with 5 IU/mL FSH, but higher in AHRKO
follicles treated with 10 or 15 IU/mL FSH compared WT fol-
licles (Figure 3B). Further, levels of Cyp19a1 mRNA were
higher in WT and AHRKO follicles treated with 5, 10, or
15 IU/mL FSH compared to follicles of the same geno-
type with no FSH treatment. In contrast, WT follicles
treated with 15 IU/mL FSH had lower levels of Cyp19a1















































































































































Figure 2 Comparison of theca-cell derived factors in response to FSH treatment in WT and AHRKO follicles. Early antral follicles from pre-
pubertal WT and AHRKO ovaries were isolated and cultured in supplemented media in the presence of 0–15 IU/mL FSH for 7 days. At the end of
culture, follicles were pooled per treatment group and genotype, subjected to extraction of RNA and then processed for qPCR analysis of Star (A),
Cyp11a1 (B), Cyp17a1 (C), or Hsd3b1 (D). Each gene was expressed as a mean relative expression ratio normalized to Actb as a loading control.
Media samples from individual follicles were obtained from cultures and subjected to ELISAs to measure levels of progesterone (E), DHEA (F)
and androstenedione (G). Each bar represents the mean ± SEM from three separate cultures per genotype at each selected treatment and from
10–18 follicles per treatment. The letter “a” above the bars indicates significant difference (p ≤ 0.05) from WT follicles within the same FSH
treatment and the letter “b” above the bars indicates significant difference (p ≤ 0.05) from 0 IU/mL FSH in the same genotype, using one-way
ANOVA followed by Tukey’s test as a post hoc test.


































































Figure 3 Comparison of granulosa-cell derived factors in
response to FSH treatment in WT and AHRKO follicles. Early
antral follicles from pre-pubertal WT and AHRKO ovaries were
isolated and cultured in supplemented media in the presence of
0–15 IU/mL FSH for 7 days. At the end of culture, follicles were
pooled per treatment group and genotype, subjected to extraction
of RNA and then processed for qPCR analysis of Fshr (A) and
Cyp19a1 (B). Each gene was expressed as a mean relative expression
ratio normalized to Actb as a loading control. Media samples from
individual follicles were obtained from cultures and subjected to
ELISAs to measure levels of estradiol (C). Each bar represents the
mean ± SEM from three separate cultures per genotype at each
selected treatment and from 10–18 follicles per treatment. The letter
“a” above the bars indicates significant difference (p ≤ 0.05) from WT
follicles within the same FSH treatment, the letter “b” above the bars
indicates significant difference (p ≤ 0.05) from 0 IU/mL FSH in the
same genotype and letter “c” above the bar indicates significant
difference (p ≤ 0.05) from WT follicles treated with 5 IU/mL FSH,
using one-way ANOVA followed by Tukey’s test as a post hoc test.
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by granulosa cells, and promotes follicle growth
[9,10,13,14], levels of estradiol were measured in media
samples collected from WT and AHRKO follicles treated
with increasing concentrations of FSH. Levels of estradiol
were similar in media from WT and AHRKO follicles cul-
tured in the presence of 15 IU/mL FSH (Figure 3C). How-
ever, levels of estradiol were decreased in media from
AHRKO follicles in the presence of 5 IU/mL FSH and in-
creased in media from AHRKO follicles cultured in the
presence of 10 IU/mL FSH compared to media from WT
follicles (Figure 3C). Further, significant increases in levels
of estradiol were observed in WT and AHRKO follicles
cultured in the presence of 5, 10, or 15 IU/mL FSH com-
pared to follicles cultured in the presence of 0 IU/mL FSH
in the same genotype (Figure 3C).
Effects of FSH on expression of Inhba
To further evaluate FSH responsiveness in AHRKO folli-
cles versus WT follicles, levels of Inhba mRNA were
compared in WT and AHRKO follicles at the end of cul-
ture (Figure 4). We elected to focus on Inhba expression
as a marker of FSH responsiveness because this follicular
factor is directly regulated by FSH through binding to
FSHR [15,16,25,26]. Increasing concentrations of FSH
(5–15 IU/mL) resulted in significantly increased levels of
Inhba mRNA to a greater degree in AHRKO follicles
than in WT follicles (Figure 4).
Discussion
While previous studies indicate that pre-pubertal
AHRKO antral follicles have slow growth and reduced
estradiol production compared to WT follicles [2-6], it
was not known whether these alterations were due to
low FSH responsiveness in AHRKO versus WT follicles.
To investigate this issue, we used an isolated follicle




















Figure 4 Comparison of Inhba mRNA levels in response to FSH
treatment in WT and AHRKO follicles. Early antral follicles from pre-
pubertal WT and AHRKO ovaries were isolated and cultured in
supplemented media in the presence of 0–15 IU/mL FSH for 7 days. At
the end of culture, follicles were pooled per treatment group and
genotype, subjected to extraction of RNA and then processed for qPCR
analysis of Inhba, which is expressed as a mean relative expression ratio
normalized to Actb as a loading control. Each bar represents the mean
± SEM (n=3-6 mice per genotype and 10–16 follicles at each selected
treatment). The letter “a” above the bars indicates significant difference
(p ≤ 0.05) from WT follicles within the same FSH treatment, and the
letter “b” above the bar indicates significant difference (p ≤ 0.05) from 0
IU/mL FSH in the same genotype, using one-way ANOVA followed by
Tukey’s test as a post hoc test.
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pre-pubertal WT and AHRKO antral follicles. Our main
findings suggest that AHRKO follicles are less responsive
to FSH-induced follicle growth than WT follicles be-
cause higher levels of FSH are required for AHRKO fol-
licles to reach the same degree of growth as WT
follicles. Surprisingly, the response of WT and AHRKO
follicles to FSH in terms of steroid hormone produc-
tion and steroidogenic regulator expression did not fol-
low the response of follicle growth to FSH. Instead,
FSH stimulated production of sex steroid hormones
and steroidogenic regulators to a similar or greater de-
gree in AHRKO follicles compared to WT follicles.
These data suggest that the AHR may contribute to
FSH-stimulated follicle growth, but it may not contrib-
ute to the ability of FSH to stimulate steroidogenesis.
Based on lower mRNA expression of Fshr as well as
reduced binding sites for FSH in AHRKO ovaries com-
pared to WT ovaries already shown in previous studies
[5,8] and the higher FSH levels needed in our experi-
ments for AHRKO follicles to reach WT growth levels,
we initially expected that FSH would not be able to
stimulate expression of Fshr to the same degree in
AHRKO follicles as it does in WT follicles. However, our
data indicate an opposite scenario in which FSH in-
creases expression of Fshr to a greater level in AHRKO
follicles compared to WT follicles. Further, our data in-
dicate that the down-regulation of Fshr expression uponrising levels of FSH occurred in WT follicles, but not in
AHRKO follicles. Because previous studies indicate that
FSH can increase its own receptor, leading to increased
ability of follicles to respond to FSH [9,27-30], our data
suggest that the reduced levels of Fshr, and thus, the re-
duced capacity of AHRKO follicles to respond to FSH
are not due to an inability of FSH to stimulate expres-
sion of its own receptor.
It is unclear how rising levels of FSH down-regulate
expression of the Fshr in WT follicles, but not in
AHRKO follicles. Previous studies indicate that low
levels of FSH may favor increased Fshr expression in
granulosa cells, whereas high levels of FSH suppress
Fshr expression in granulosa cells [29]. It is possible
that differences in Fshr transcript levels in WT and
AHRKO follicles treated with rising levels of FSH
may be explained by findings suggesting that the
AHR is recruited to the Fshr promoter to transcribe
the Fshr in WT, but not AHRKO follicles [5]. As FSH
levels increase in WT follicles, the high FSH levels
may lead to down-regulation of the Fshr. In AHRKO
follicles, however, there is no active AHR; therefore,
Fshr transcription may occur independently of the
AHR. The AHR has been suggested to be indispensable
for proper transcription of Cyp19a1 in the ovary [4]. In
our experiments, however, Cyp19a1 as well as Inhba
transcription followed a very similar pattern in re-
sponse to FSH in AHRKO follicles compared to WT
follicles, suggesting that FSH regulation of Cyp19a1
and Inhba may not directly require the presence of
the AHR. Instead, they may require proper transcrip-
tion of Fshr.
Our experiments used a minimal concentration of 5
IU/mL FSH, which has been shown to be an essential
dose for sustaining in vitro follicle growth [6,20]. Be-
cause the physiological doses of FSH that are required to
promote growth in antral follicles are unknown, our use
of a range of doses of FSH allowed us to compare FSH
responsiveness in WT and AHRKO follicles. Unexpect-
edly, follicles were still able to grow to some degree
when FSH was omitted from the culture. This finding is
supported by previous studies that have demonstrated
that FSHR knockout mice can develop pre-antral folli-
cles up to the early antral follicle stage, but not further
[31-33]. In addition, follicles cultured with no FSH treat-
ment during the antral phase have limited granulosa cell
differentiation in terms of their ability to produce estra-
diol [34]. As shown in our experiments, estradiol pro-
duction and hormone precursors in follicles cultured
with no FSH treatment were lower than those cultured
with FSH treatment regardless of genotype. Since our
in vitro culture uses a luteinizing hormone (LH)-free
culture medium, androgen levels may be the result of
constitutive androgen production by the theca cells,
Hernández-Ochoa et al. Reproductive Biology and Endocrinology 2013, 11:26 Page 9 of 10
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Conclusions
In summary, our data indicate that higher levels of FSH
are required to stimulate follicle growth in AHRKO folli-
cles compared to WT follicles. In contrast, FSH is able
to stimulate expression of steroidogenic factors, Fshr,
and Inhba as well as production of some sex steroid hor-
mones to a similar or greater degree in AHRKO follicles
compared to WT follicles. Collectively, these data sug-
gest that the AHR may contribute to the ability of FSH
to stimulate proper follicle growth, but it may not con-
tribute FSH-stimulated steroidogenesis.
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